EVP Lane Michael sold 8,411 shares at $627.56–$628.89 for $5.3M; position cut 54.1%, leaving 7,131 shares held.
Lane Michael, Executive Vice President of IDEXX LABORATORIES, executed 3 separate sales totaling 8,411 shares for $5,279,893.42 on 2025-08-06, reducing his holdings by 54.1% from 15,542 to 7,131 shares. The blended average sale price of $627.74 sits below the current price of $658.06, and the 30-day change shows +21.7% upward momentum. Notably, his prior sell at this same ticker (2023-08-03) was well-timed at the 90-day mark, with the stock declining -22.5% after the sale. This current substantial reduction in shareholding—eliminating more than half his position—occurs in a market environment where IDXX has risen strongly in recent months (+33.8% over 90 days), and at a valuation of 53.41 P/E. The scale and timing of this liquidation relative to his prior sell pattern merit investor attention as a data point in assessing sentiment among senior management.